CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

AIM2-driven inflammasome activation in heart failure Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry Criteria for Iron Deficiency in Patients With Heart Failure 21st Century CE: The New Iron Age? 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study

Original Research2021 Jun 12;cvab202.

JOURNAL:Cardiovasc Res. Article Link

AIM2-driven inflammasome activation in heart failure

Z Onódi, M Ruppert, D Kucsera et al. Keywords: canakinumab; cardiomyopathy; drug repurposing; heart failure; inflammation; probenecid

Full Text PDF